celecoxib/tramadol (YYC301) / Yooyoung Pharma, Yuhan Corp - LARVOL DELTA

Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee (clinicaltrials.gov) - P3 | N=692 | Recruiting | Sponsor: Yooyoung Pharmaceutical Co., Ltd.

New P3 trial • Immunology • Osteoarthritis • Pain • Rheumatology

The first celecoxib + tramadol combination…[Google translation] - "Yooyoung Pharmaceutical has started recruiting a joint development company after receiving approval for the phase 3 combination of celecoxib and tramadol, a complex pain reliever....According to industry sources on the 3rd, Yooyoung Pharmaceutical received approval from the Ministry of Food and Drug Safety last year for a phase 3 clinical trial plan (IND) of 'YYC301', a combination of celecoxib and tramadol, and is in progress."

Trial status • CNS Disorders • Osteoarthritis • Pain

Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee (clinicaltrials.gov) - P2; N=261; Completed; Sponsor: Yooyoung Pharmaceutical Co., Ltd.; Not yet recruiting ➔ Completed; Trial completion date: Oct 2019 ➔ Sep 2020; Trial primary completion date: Jun 2019 ➔ May 2020

Clinical • Trial completion • Trial completion date • Trial primary completion date • Immunology • Osteoarthritis • Pain • Rheumatology